Posters

Comparison between multifocal ERG and C-scan SD-OCT ('en face' OCT) in patients with a suspicion of anti malarial retinal toxicity: Preliminary results

Poster Details

First Author: M.Costantini FRANCE

Co Author(s):    C. Arndt   C. Chiquet   M. Afriat   V. Vasseur   A. Ducasse   M. Mauget Faysse              

Abstract Details



Purpose:

Pericentral visual field changes and disruption of the ellipsoid layer on Spectral Domain optical coherence tomography (SD-OCT) are the main features of antimalarial retinal toxicity. C-Scan OCT or “en face” enables a topographic frontal view of the changes observed within the different retinal layers in particular the ellipsoid layer. The aim of this prospective study was to compare multifocal ERG (mfERG) responses with the results of C-Scan OCT ('en face' OCT) and to analyze disparities between the structural and functional findings.

Setting:

o

Methods:

In consecutive patients screened for anti-malarial toxicity between January 1st 2014 and December 31st 2016, central visual field, mfERG recording, C-Scan OCT and short-wavelength fundus autofluorescent imaging (FAF) were performed.

Results:

Among the 17 patients with abnormal central visual field results, all presented with abnormalities on both mfERG and C-Scan OCT at least in one eye. In 16/33 eyes, there was a good correlation between focal loss of the mfERG response and the disruption of the ellipsoid layer on C-Scan OCT. In one eye with characteristic changes in the ellipsoid layer on the C-Scan OCT, the mfERG was normal, whereas in three eyes the mfERG was abnormal in eyes with a normal C-Scan OCT.

Conclusions:

The functional support of the C-Scan OCT changes remains difficult to establish as there is no strict correlation with the local ERG responses. Although C-Scan OCT technology provides a new approach in analyzing focal abnormalities in the photoreceptor-retinal pigment epithelium interface, the sensitivity of this method compared with mfERG and other tests (central visual field, B- Scan OCT) needs to be evaluated. This study is still ongoing on a larger cohort.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy